Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
81
datasets available to search
ShareScore release 0.9.0
Dataset results
81 results for “nasopharyngeal cancer”
Development and validation of the Health Belief Model questionnaire to promote smoking cessation for nasopharyngeal cancer prevention: a cross-sectional study
<p>Objective: Nasopharyngeal cancer (NPC) risk factors caused by lifestyle choices are substantial yet avoidable. Using the Health Belief Model as a conceptual framework, this study develops and validates a questionnaire to predict smokers' intentions to quit in Sarawak, Malaysia (HBM).</p> <p>Design: A cross sectional study.</p> <p>Setting: Urban and suburban areas in Sarawak, Malaysia.</p> <p>Participants: Following a thorough literature study, the preliminary items for the instrument were created. Prior to beginning the content validity by a panel of 10 experts, the instrument was translated into the Malay language utilising the forward-backwards approach. 10 smokers carried out face validity in both quantitative and qualitative ways. Exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) were used to assess the instrument's concept validity. Phase 1 of the EFA involved 100 smokers, whereas phase 2 of the CFA involved 171 smokers. Cronbach's alpha coefficients were used to measure internal consistency and assess reliability.</p> <p>Results: The factor loading of each item remained within the acceptable threshold in the exploratory stage. The final revised CFA yielded the following model fit indices that suitably fitted the seven-factor model: Chi Square: 641.705; df= 500; P< 0.001; CFI = 0.953; TLI: 0.948; RMSEA= 0.041. With the exception of one pairwise construct, satisfactory convergent validity and divergent validity were demonstrated. Phases 1 and 2 both have Cronbach's alpha values over 0.7, suggesting acceptable internal reliability.</p> <p>Conclusions: The study confirmed the validity and reliability of the instrument in predicting smokers' tendency to adopt healthy behaviour of smoking cessation to lower risk of developing cancer. The instrument consists of 34 items, dividing into two sections: 6 HBM components and health behavioural intention. The instrument is regarded as innovation and can be applicable in other smoking-related malignancies in different susceptible populations and geographical locations.</p>
A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal Cancer
ClinicalTrials.gov study NCT00603915. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer (NPC)
ClinicalTrials.gov study NCT03924986. IPD Sharing: YES. Countries: 3. Publications: 2.
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
ClinicalTrials.gov study NCT00408694. IPD Sharing: Not stated. Countries: 2. Publications: 2.
Radiation Therapy, Amifostine, and Chemotherapy in Treating Young Patients With Newly Diagnosed Nasopharyngeal Cancer
ClinicalTrials.gov study NCT00274937. IPD Sharing: Not stated. Countries: 3. Publications: 2.
Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal Cancer
ClinicalTrials.gov study NCT00057785. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Nivolumab in Treating Patients With Recurrent and/or Metastatic Nasopharyngeal Cancer
ClinicalTrials.gov study NCT02339558. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Development and validation of the Health Belief Model questionnaire to promote smoking cessation for nasopharyngeal cancer prevention: a cross-sectional study
Open the record for dataset details and reuse information.
Impact of Epstein Barr Virus Infection on Treatment Opportunities in Patients with Nasopharyngeal Cancer
<p>I upload the images of the manuscript "Impact of Epstein Barr Virus Infection on Treatment Opportunities in Patients with Nasopharyngeal Cancer"</p>
A Study of Lymphangiogenesis in Colorectal and Nasopharyngeal Cancer
ClinicalTrials.gov study NCT00943891. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer
ClinicalTrials.gov study NCT05305131. IPD Sharing: NO. Countries: 1. Publications: 13.
Pilot Study of Somatostatin Receptor Imaging in Nasopharyngeal Cancer
ClinicalTrials.gov study NCT03670342. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
ClinicalTrials.gov study NCT02135042. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Swallowing Exercises for Nasopharyngeal Cancer After Radiation Therapy
ClinicalTrials.gov study NCT01937793. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122/KEYNOTE-122)
ClinicalTrials.gov study NCT02611960. IPD Sharing: YES. Countries: 0. Publications: 2.
Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers
ClinicalTrials.gov study NCT00828386. IPD Sharing: Not stated. Countries: 4. Publications: 2.
New Approach of Assessing Drug Response for Treatment of Nasopharyngeal Cancer
ClinicalTrials.gov study NCT01365208. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer
ClinicalTrials.gov study NCT00078494. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Swallowing Pattern of Patients With Nasopharyngeal Cancer Before and After Radiation Therapy: Longitudinal Study and Correction With Saliva Amount
ClinicalTrials.gov study NCT00173836. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer
ClinicalTrials.gov study NCT01614938. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.